The forecast for hospital discharges for malignant neoplasm of the uterus in Germany shows a gradual decline from 2024 to 2028. In 2023, the value stood at approximately 38.3 thousand. From 2024, with the value at 38.18 thousand, there is a small decrease each subsequent year, with 2028 projected at 37.7 thousand. The year-on-year percentage variation is minor, indicating a consistent but slow downward trend. Over the forecasted period, the Compound Annual Growth Rate (CAGR) reflects a slight but steady decrease annually.
Future trends to watch for include potential impacts of advancements in medical treatments and technologies on hospital discharge rates and any shifts in healthcare policies or demographic changes which could influence the prevalence of uterine neoplasms and hospitalization needs.
